We value your privacy

This website or its third-party tools process personal data. You can opt out of the sale of your personal information by clicking on the “Do Not Sell or Share My Personal Information” link.

Powered by

Maxalt

ACNU Feasibility

View full report
GoodMaxalt is an oral prescription triptan with moderate side effects and drug interactions, requires careful dosing and monitoring, especially in special populations, but has low misuse risk and generally good adherence for episodic migraine treatment.

ACNU Feasibility Scorecard

Chart with 11 data points.
Maxalt
The chart has 1 X axis displaying categories.
The chart has 1 Y axis displaying ← Lower is Better!. Data ranges from 1 to 6.
End of interactive chart.